90Y-HPAM4 Uses, Dosage, Side Effects and more
90Y-HPAM4 is under investigation in clinical trial NCT00603863 (Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer).
| Trade Name | 90Y-HPAM4 |
| Generic | Yttrium Y-90 clivatuzumab tetraxetan |
| Yttrium Y-90 clivatuzumab tetraxetan Other Names | 90Y-HPAM4 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
